|Project #||Project Title||Research Focus Area||Research Program||Administering IC||Institution(s)||Investigator(s)||Location(s)||Year Awarded|
|The Hemodialysis Opioid Prescription Effort Consortium||Clinical Research in Pain Management||Integrated Approach to Pain and Opioid Use in Hemodialysis Patients||NIDDK||HENNEPIN HEALTHCARE RESEARCH INSTITUTE||JOHANSEN, KIRSTEN L (contact); BART, GAVIN ; KREBS, ERIN ELIZABETH; LIU, JIANNONG||Minneapolis, MN||2019|
NOFO Title: HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required)
NOFO Number: RFA-DK-18-030
Despite the pervasive use of opioid analgesics in the dialysis population and the substantial risks they engender, their efficacy is limited in treating common chronic pain conditions. Most patients receiving long-term opioid therapy continue to experience severe pain and functional limitations. To simultaneously address problems related to chronic pain and opioid use in the U.S. hemodialysis population, this study will evaluate tailored patient-centered interventions to manage pain and reduce opioid use. Patients will be assigned randomly to one of three groups over a 12-month study period: 1) pain care management (PCM) versus 2) PCM plus an online pain self-management program (PSM) that incorporates cognitive behavioral training and is delivered during dialysis sessions, versus 3) control with medication review and education. The study will also evaluate the effectiveness of offering buprenorphine by randomly assigning participants in both active treatment arms to being offered buprenorphine rotation versus continued standard opioid taper support without the option of buprenorphine.